REWIND THERAPEUTICS
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medical practitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
REWIND THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2017-01-01
Address:
Antwerp, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.rewindtherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18.1 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Investors List
Flanders Innovation and Entrepreneurship (VLAIO)
Flanders Innovation and Entrepreneurship (VLAIO) investment in Grant - Rewind Therapeutics
M Ventures
M Ventures investment in Series A - Rewind Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Rewind Therapeutics
Gemma Frisius Fund
Gemma Frisius Fund investment in Series A - Rewind Therapeutics
Centre for Drug Design & Discovery (CD3)
Centre for Drug Design & Discovery (CD3) investment in Series A - Rewind Therapeutics
PMV
PMV investment in Series A - Rewind Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer |
Official Site Inspections
http://www.rewindtherapeutics.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K
- Host name: 217.19.237.54.static.hosted.by.combell.com
- IP address: 217.19.237.54
- Location: Brussels Belgium
- Latitude: 50.8336
- Longitude: 4.3337
- Timezone: Europe/Brussels
- Postal: 1060
More informations about "Rewind Therapeutics"
Rewind Therapeutics – The Power of Remyelination
Rewind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, …See details»
Team – Rewind Therapeutics
In addition to his role at Rewind Therapeutics, he is currently Director of Discovery and Preclinical Projects at 3D Consultants, Cambridge (UK), an advisory company focusing on drug discovery …See details»
Rewind Therapeutics - Crunchbase Company Profile & Funding
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory …See details»
Rewind Therapeutics - LinkedIn
Rewind Therapeutics | 2,472 followers on LinkedIn. Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track ...See details»
Rewind Therapeutics | Boehringer Ingelheim Venture Fund
Rewind Therapeutics has established a leading-edge knowledge base in the field of remyelination and is currently advancing its lead development candidate with significant therapeutic potential …See details»
ReWind Therapeutics Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ReWind Therapeutics of Leuven. Get the latest business insights from Dun & Bradstreet. ReWind …See details»
Rewind Therapeutics Company Profile - Office Locations ... - Craft
Rewind Therapeutics has 5 employees at their 1 location and $21.51 m in total funding,. See insights on Rewind Therapeutics including office locations, competitors, revenue, financials, …See details»
Rewind Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Rewind Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Rewind Therapeutics - VentureRadar
Rewind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, …See details»
Rewind Therapeutics - Overview, News & Similar companies
Rewind Therapeutics works in close collaboration with both organisations and a world-class academic network to advance its discovery and development activities. Rewind Therapeutics …See details»
Rewind Therapeutics | Startup Profile and Investments
Rewind Therapeutics - Company Details Rewind Therapeutics is a biotechnology startup founded in 2017, dedicated to pioneering novel treatments for neurological diseases. The company's …See details»
Scientific Background – Rewind Therapeutics
Rewind Therapeutics’ goal is to develop novel therapeutics that promote effective remyelination in the CNS. Developing novel remyelination therapeutics . If you have any questions please …See details»
Rewind Therapeutics 2025 Company Profile: Valuation, Funding ...
Rewind Therapeutics General Information Description. Developer of remyelinating therapeutics designed to facilitate the treatment of neurological diseases. The company's therapeutics …See details»
Rewind Therapeutics | PMV
Rewind Therapeutics aims to repair the damage to the myelin itself, thus slowing or even curing the disease. This would be a very important breakthrough for the many MS patients. Partners …See details»
New hope for treating demyelinating diseases - Rewind …
Feb 1, 2023 Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated diseases, announced that it has raised additional funding, with …See details»
Approach & Pipeline – Rewind Therapeutics
Rewind Therapeutics´ highly experienced, international team has established a leading-edge knowledge base in the field of remyelination. The Company aims to decipher and re-establish …See details»
Rewind’s Remyelinating Therapy Pipeline Backed by New …
Jan 31, 2023 Rewind Therapeutics has received new investments to support the development of its therapeutic candidates designed to promote remyelination in neurodegenerative diseases …See details»
rewindtherapeutics.com: Revenue, Competitors, Alternatives
Rewindtherapeutics.com 's estimated revenue per employee is $ 155,000Employee Data. rewindtherapeutics.com has 26 Employees. rewindtherapeutics.com; grew their employee …See details»
Rewind Therapeutics - Overview, News & Similar companies
Who is Rewind Therapeutics. Rewind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debi litating diseases …See details»
Remyelination therapy(Rewind) - Drug Targets, Indications
Last update 20 Mar 2025. Overview. R&D StatusSee details»